42C Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - IX Biopharma Ltd

Watchlist Manager

Watchlist

Price: 0.57 SGD -5%

Market Cap: S$623.2m

I	IX Biopharma Ltd SGX:42C	SG

Profitability Summary

IX Biopharma Ltd's profitability score is 11/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

30%

Sustainable 3Y Average Gross Margin

26%

Declining Gross Margin

39% > 30%

Negative Operating Margin

-72%

Negative 3Y Average Operating Margin

-93%

Operating Margin is Increasing

-143% > -72%

Negative Net Margin

-78%

Negative 3Y Average Net Margin

-128%

Net Margin is Increasing

-163% > -78%

Negative Free Cash Flow Margin

-77%

Negative 3Y Average Free Cash Flow Margin

-83%

Free Cash Flow Margin is Increasing

-141% > -77%

Negative ROE

-67%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-80%

Declining ROIC

-60% > -90%

View All

Hide

Collapse

11 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.